Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

Phase 1

4(57.1%)

N/A

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 1(4)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01258231Recruiting

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Role: collaborator

NCT00314366Phase 1Completed

Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)

Role: lead

NCT00691756Not ApplicableCompleted

A Comparison of Renal Perfusion in Thoracoabdominal Aortic Aneurysm (TAAA) Repair

Role: collaborator

NCT02248974Not ApplicableCompleted

Development & Testing of a Decision Aid for LVAD Placement

Role: collaborator

NCT00585546Phase 1Terminated

Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure

Role: collaborator

NCT00203203Phase 1Completed

Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)

Role: lead

NCT00313339Phase 1Completed

Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction

Role: collaborator

NCT00617318Phase 3Completed

Pomegranate Products for Prevention of Common Cold

Role: lead

All 8 trials loaded